1. Zhang J, Chen Y, Wang Z, Chen X, Liu Y, Liu M. Anatomic distribution of lower extremity deep venous thrombosis is associated with an increased risk of pulmonary embolism: a 10-year retrospective analysis. Front Cardiovasc Med. 2023;10:1154875. doi:10.3389/fcvm.2023.1154875
2. Yao M, Ma J, Wu D, et al. Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy. Front Immunol. 2023;14:1198952. doi:10.3389/fimmu.2023.1198952
3. Navarrete S, Solar C, Tapia R, Pereira J, Fuentes E, Palomo I. Pathophysiology of deep vein thrombosis. Clin Exp Med. 2023;23(3):645-654. doi:10.1007/s10238-022-00829-w
4. Li Y, He Y, Meng Y, et al. Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients. Sci Rep. 2022;12(1):649. doi:10.1038/s41598-021-04657-y
5. van Es N, Takada T, Kraaijpoel N, et al. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis. Eur Heart J. 2023;44(32):3073-3081. doi:10.1093/eurheartj/ehad417
6. Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. doi:10.1016/j.metabol.2021.154766
7. Zhang B, Lei H, Ambler G, et al. Association between triglyceride-glucose ındex and early neurological outcomes after thrombolysis in patients with acute ıschemic stroke. J Clin Med. 2023;12(10):3471. doi:10.3390/jcm 12103471
8. Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124. doi:10.1186/s12933-022-01546-0
9. Yan Y, Zhou L, La R, et al. The association between triglyceride glucose index and arthritis: a population-based study. Lipids Health Dis. 2023;22(1):132. doi:10.1186/s12944-023-01899-9
10. Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. 2022;21(1):68. doi: 10.1186/s12933-022-01511-x
11. Tian X, Zuo Y, Chen S, et al. Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2021;20(1):19. doi:10.1186/s12933-020-01210-5
12. Cui H, Liu Q, Wu Y, Cao L. Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):22. doi:10.1186/s12933-022-01456-1
13. Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76. doi:10.1186/s12933-021-01268-9
14. Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124. doi:10.1186/s12933-022-01546-0
15. Karande GY, Hedgire SS, Sanchez Y, et al Advanced imaging in acute and chronic deep vein thrombosis. Cardiovasc Diagn Ther. 2016;6(6):493-507. doi:10.21037/cdt.2016.12.06
16. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299-304. doi:10.1089/met.2008.0034
17. Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19(10):654-672. doi:10.1038/s41580-018-0044-8
18. Zhang B, Liu L, Ruan H, et al. Triglyceride-glucose index linked to hospital mortality in critically ill stroke: an observational multicentre study on eICU database. Front Med (Lausanne). 2020;7:591036. doi:10.3389/fmed.2020. 591036
19. Zhou Y, Pan Y, Yan H, et al. Triglyceride glucose index and prognosis of patients with ischemic stroke. Front Neurol. 2020;11:456. doi:10.3389/fneur.2020.00456
20. Gok M, Kurtul A. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J. 2021;55(2):91-96. doi:10.1080/14017431.2020.1846774
21. van Schouwenburg IM, Mahmoodi BK, Veeger NJ, et al. Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. J Thromb Haemost. 2012;10(6):1012-1018. doi:10.1111/j.1538-7836. 2012.04707.x
22. Kain K, Catto AJ, Grant PJ. Associations between insulin resistance and thrombotic risk factors in high-risk south Asian subjects. Diabet Med. 2003;20(8):651-655. doi:10.1046/j.1464-5491.2003.00958.x
23. Deng XL, Liu Z, Wang C, Li Y, Cai Z. Insulin resistance in ischemic stroke. Metab Brain Dis. 2017;32(5):1323-1334. doi:10.1007/s11011-017-0050-0
24. Lu H, Lei S, Zhao J, Chen N. Platelet activity in Chinese obese adolescents with and without insulin resistance. J Thromb Thrombolysis. 2014;37(2):165-170. doi:10.1007/s11239-013-0917-9
25. Palomo I, Alarcón M, Moore-Carrasco R, Argilés JM. Hemostasis alterations in metabolic syndrome. Int J Mol Med. 2006;18(5):969-974. doi: 10.3892/ijmm.18.5.969
26. Carter AM, Cymbalista CM, Spector TD, Grant PJ. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol. 2007;27(12):2783-2789. doi:10.1161/ATVBAHA.107.153221
27. Singh S, Goel A. A study of modified Wells score for pulmonary embolism and age-adjusted D-dimer values in patients at risk for deep venous thrombosis. J Family Med Prim Care. 2023;12(9):2020-2023. doi:10.4103/jfmpc.jfmpc_2455_22
28. Perrier A, Roy PM, Aujesky D, et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med. 2004;116(5):291-299. doi:10.1016/j.amjmed.2003.09.041
29. Gong B, Xu Q, Pang Y, Hu, J. Clinical features of patients with venous thromboembolism: 177 case analysis in 10 years. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(4):453-457. doi:10.3760/cma.j.issn.2095-4352. 2019.04.016
30. Leibson CL, Petterson TM, Smith CY, et al. Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments. Chest. 2014;146(2):412-421. doi:10.1378/chest.13-2652
31. Abdelmalik BH, Leslom MMA, Gameraddin M, et al. Assessment of lower limb deep vein thrombosis: characterization and associated risk factors using triplex Doppler imaging. Vasc Health Risk Manag. 2023;19:279-287. doi:10.2147/VHRM.S409253
32. Roy PM, Friou E, Germeau B, et al. Derivation and validation of a 4-level clinical pretest probability score for suspected pulmonary embolism to safely decrease imaging testing. JAMA Cardiol. 2021;6(6):669-677. doi:10. 1001/jamacardio.2021.0064
33. Chung WS, Lin CL, Kao CH. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Thromb Haemost. 2015;114(4):812-818. doi:10.1160/TH14-10-0868
34. Fabbian F, Gallerani M, Pala M, et al. In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy. Intern Emerg Med. 2013;8(8):735-740. doi: 10.1007/s11739-012-0892-8
35. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162(10):1182-1189. doi:10.1001/archinte.162.10.1182
36. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005;48(5):1017-1021. doi:10.1007/s00125-005-1715-5
37. Peng YH, Lin YS, Chen CH, et al. Type 1 diabetes is associated with an increased risk of venous thromboembolism: a retrospective population-based cohort study. PLoS One. 2020;15(1):e0226997. doi:10.1371/journal.pone.0226997
38. Schmitt VH, Hobohm L, Munzel T, Wenzel P, Gori T, Keller K. Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction. Diabetes Metab. 2021;47(4):101211. doi:10.1016/j.diabet.2020.11.003
39. Giannini C, Mohn A, Chiarelli F, Kelnar CJ. Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab Res Rev. 2011;27(5):436-460. doi:10.1002/dmrr.1195
40. Zhang C, Li Q, Yu H, et al. Relationship between the site of thrombosis and the prevalence of pulmonary embolism in acute lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020;8(5):725-733. doi:10.1016/j.jvsv.2019.11.010
41. Qiu T, Zhang T, Liu L, et al. The anatomic distribution and pulmonary embolism complications of hospital-acquired lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2021;9(6):1391-1398.e3. doi:10.1016/j.jvsv.2021.03.004
42. Konstantinides SV, Torbicki A, Agnelli G, et al. Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2015;36(39):2666. doi:10.1093/eurheartj/ehv131